PETS vs PRPO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PETS exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by catastrophic fundamental decay. The company is experiencing a severe collapse in profitability with an ROE of -100.61% and accelerating revenue declines (-21.7% YoY, -29.95% Q/Q). Despite a very low Debt/Equity ratio, the current ratio of 0.89 indicates immediate liquidity risks, while a 0/4 earnings beat record over the last year suggests a complete loss of operational control.
PRPO exhibits a severe disconnect between its recent price appreciation (+381% 1Y) and its fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the company shows promising top-line growth (22.9% YoY) and a positive operating margin (8.09%), it remains net-unprofitable with a prohibitively high Forward P/E of 72.56. The technical trend has collapsed to 10/100, suggesting the recent rally was speculative and is now reversing. Overall, the combination of weak deterministic health scores and extreme valuation makes the current price unsustainable.
Compare Another Pair
Related Comparisons
PETS vs PRPO: Head-to-Head Comparison
This page compares PetMed Express, Inc. (PETS) and Precipio, Inc. (PRPO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.